or Try an Advanced Search...

    ETF Components for MNTL - Tema Neuroscience and Mental Health ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY C -0.48 4.77
    VRTX C -0.41 4.62
    REGN C 0.67 4.43
    NBIX B 0.40 4.27
    DNLI F 0.11 3.87
    SYK D 0.57 3.84
    BIIB C 0.35 3.72
    DXCM D 1.34 3.67
    ARGX D -2.05 3.57
    CRNX B -0.92 3.18

    Represented by ETF Holdings

    Keywords: S&P 500 Medicine Nasdaq 100 Alzheimer's Disease Biopharmaceutical Diabetes Pain Autoimmune Disease Biotechnology Breakthrough Therapy Cancer Cardiovascular Disease Cholesterol Clinical Development Degenerative Disease Disorders Endocrine System Endocrinology Immunology Inflammation
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Medical Devices

    Recent News for Tema Neuroscience and Mental Health ETF & its Holdings

    Date Stock Title
    May 9 LLY Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
    May 9 LLY Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
    May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
    May 9 ARGX argenx misses top-line and bottom-line estimates; updates FY24 outlook
    May 9 ARGX argenx Reports First Quarter 2024 Financial Results and Provides Business Update
    May 9 VRTX Dow Jones Futures: S&P 500 Holds, Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers Late
    May 8 CRNX Crinetics Pharmaceuticals Q1 2024 Earnings Preview
    May 8 CRNX Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
    May 8 VRTX A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
    May 8 BIIB Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
    May 8 VRTX Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
    May 8 ARGX Argenx SE Q1 2024 Earnings Preview
    May 8 LLY Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
    May 8 BIIB Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
    May 8 VRTX Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
    May 8 VRTX Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
    May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
    May 8 DNLI Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
    May 8 REGN Regeneron gene therapy improves hearing in child deafness
    May 8 DXCM Estimating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
    Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.
    Neuroscience Neurophysiology Neurology Nervous System
    Back to the Main MNTL Page...